Sequence Similarity Clusters for the Entities in PDB 3HI1

Entity #1 | Chains: G,J
Glycoprotein 120 protein, length: 321 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 17779
95 % 1 2 16395 Flexibility: Medium
Max RMSD: 6.7, Avg RMSD: 4.6
PDBFlex
90 % 7 13 2855
70 % 86 182 132
50 % 86 182 161
40 % 86 182 172
30 % 86 185 188
Entity #2 | Chains: A,L
F105 Light Chain protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 27637
95 % 64 94 232 Flexibility: Low
Max RMSD: 6.2, Avg RMSD: 1.8
PDBFlex
90 % 533 783 2
70 % 1747 2576 1
50 % 3549 5225 1
40 % 4018 5883 1
30 % 4988 7321 1
Entity #3 | Chains: B,H
F105 Heavy Chain protein, length: 225 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 25613
95 % 1 2 25776 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.5
PDBFlex
90 % 41 67 293
70 % 1714 2532 2
50 % 3550 5225 1
40 % 4019 5883 1
30 % 4989 7321 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
34 6EH4 2 E Human T Cell Receptor Beta Chain 9606
35 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
36 4BUH 1 A, B CLONE M0418 SCFV 9606
37 4B50 1 A 2H10 LLAMA VHH 9844
38 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
39 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
40 6FR4 1 A TCR 003 alpha chain 9606
41 6FR4 2 B TCR 003 Beta Chain 9606
42 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
43 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
44 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
45 6EH5 2 B Human T Cell Receptor Beta Chain 9606
46 5YD4 1 A, C, E, G scFv 4B08 10090
47 5YD3 1 A, C, E, G scFv 4B08 10090
48 2XT1 2 B CAMELID VHH 9 30538
49 5UD9 1 H Fab heavy chain 9606
50 5UD9 2 L Light chain 9606
51 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
52 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
53 4P48 1 A Antibody scFv 180 9031
54 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
55 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
56 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
57 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
58 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
59 6FR3 1 A 003 TCR Alpha Chain 9606
60 6FR3 2 B 003 TCR Beta Chain 9606
61 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
62 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
63 5J1S 3 C VHH domain BS-2 30538
64 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
65 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
66 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
67 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
68 5L6Q 1 A, B H5AL 9606
69 5J1T 3 C VHH domain BS-2 30538
70 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
71 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
72 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
73 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
74 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
75 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
76 4XCF 1 L 4E10 Fab light chain 9606
77 4XCF 2 H 4E10 Fab heavy chain 9606
78 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
79 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
80 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
81 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
82 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
83 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
84 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
85 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
86 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
87 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
88 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
89 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
90 5X08 1 H Fab 4E10 Heavy chain 9606
91 5X08 2 L Fab 4E10 Light chain 9606
92 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
93 2X1O 1 A, B GELSOLIN NANOBODY 9844
94 4QGY 1 A, B nanobody n25, VH domain 9844
95 5C2B 1 H scFv 3B4 heavy chain 9606
96 5C2B 2 L 3B4 light chain 9606
97 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
98 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
99 4XAW 1 L 4E10 Fab light chain 9606
100 4XAW 2 H 4E10 Fab heavy chain 9606
101 5VNV 1 A Nb.b201 32630
102 4P49 1 A Antibody scFv B8 9031
103 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
104 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
105 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
106 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
107 5DXW 1 A PD-L1 nanobody 10090
108 2NW2 1 A ELS4 TCR alpha chain 9606
109 2NW2 2 B ELS4 TCR beta chain 9606
110 5UCB 1 H Fab Heavy Chain 9606
111 5UCB 2 L Fab Light Chain 9606
112 3T0W 1 A, B immunoglobulin variable lambda domain 9606
113 2VXV 1 H HUMAN IGG ABT-325 9606
114 2VXV 2 L HUMAN IGG ABT-325 9606
115 4N9O 2 B Nanobody Nb484 Nb484 9844
116 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
117 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
118 3T0V 1 A immunoglobulin variable lambda domain 9606
119 4GXV 1 H, I Antibody 1F1, heavy chain 9606
120 4GXV 2 L, M Antibody 1F1, light chain 9606
121 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
122 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
123 2VXT 1 H MURINE IGG 125-2H 10090
124 2VXT 3 L MURINE IGG 125-2H 10090
125 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
126 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
127 1T2J 1 A M12-Variable Heavy domain 9606
128 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
129 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
130 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
131 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
132 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
133 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
134 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
135 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
136 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
137 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
138 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
139 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
140 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
141 5W24 1 L 5C4 Fab Light Chain 10090
142 5W24 2 H 5C4 Fab Heavy Chain 10090
143 4HPY 1 H CH59 Fab heavy chain 9606
144 4HPY 2 L CH59 Fab light chain 9606
145 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
146 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
147 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
148 5VM6 1 A single domain camelid nanobody VHH T10 9844
149 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
150 4JG1 1 L Fab light chain 9606
151 4JG1 2 H Fab heavy chain 9606
152 1SQ2 2 N novel antigen receptor 7801
153 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
154 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
155 4KML 2 B Nanobody 9844
156 5VF2 1 A scFv 2D10 10090
157 5I8C 1 A VRC34.01 Fab heavy chain 9606
158 5I8C 2 B VRC34.01 Fab light chain 9606
159 4O5L 1 L Fab F045-092 light chain 9606
160 4O5L 2 H Fab F045-092 heavy chain 9606
161 5MYX 1 A, C Fab c#24 light chain 10090
162 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
163 4Z9K 2 B VHH2(F5) antibody 30538
164 3IFL 1 L 12A11 FAB antibody light chain 10090
165 3IFL 2 H 12A11 FAB antibody heavy chain 10090
166 5WK2 1 L M116 LIGHT CHAIN 9606
167 5WK2 2 H M116 HEAVY CHAIN FD 9606
168 3PP4 1 H GA101 Fab heavy chain 10090
169 3PP4 2 L GA101 Fab light chain 10090
170 3KDM 1 A, L Immunoglobulin light chain 9606
171 3KDM 2 B, H Immunoglobulin heavy chain 9606
172 5NIV 1 A Light chain of 5D3 Fab 10090
173 5NIV 2 B Heavy chain of 5D3 Fab 10090
174 5N4J 1 L LIGHT CHAIN 9606
175 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
176 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
177 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
178 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
179 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
180 5X4G 1 A 6H8 Fab heavy chain 10090
181 5X4G 2 B 6H8 Fab light chain 10090
182 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
183 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
184 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
185 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
186 4PTU 1 A Antibody pn132p2C05, light chain 9606
187 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
188 4TPR 1 L If kappa light chain 10090
189 4TPR 2 H Fab heavy chain 10090
190 5LMW 1 A Nanobody 9844
191 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
192 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
193 3IFN 1 H 12A11 FAB antibody heavy chain 10090
194 3IFN 2 L 12A11 FAB antibody light chain 10090
195 5U3P 1 H DH511.4 Fab Heavy Chain 9606
196 5U3P 2 L DH511.4 Fab Light Chain 9606
197 6BLA 1 H AMM01 Fab Heavy chain 9606
198 6BLA 2 L AMM01 Fab Light chain 9606
199 5NM0 1 A, B, C, D Nb36 9844
200 4TOY 1 H 35O22 Fab Heavy chain 9606
201 4TOY 2 L 35O22 Fab Light chain 9606
202 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
203 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
204 3NPS 2 B S4 FAB HEAVY CHAIN 9606
205 3NPS 3 C S4 FAB LIGHT CHAIN 9606
206 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
207 5I4F 1 A scFv 2D10 10090
208 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
209 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
210 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
211 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
212 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
213 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
214 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
215 5WN9 1 H scFv 2D10 9606
216 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
217 4XC3 1 L 4E10 Fab light chain 9606
218 4XC3 2 H 4E10 Fab heavy chain 9606
219 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
220 4PPT 1 A Engineered single domain VHH antibody 9844
221 3R0M 1 A, B Llama VHH A12 9844
222 4M5Y 1 H, I Fab 5J8 heavy chain 9606
223 4M5Y 2 L, M Fab 5J8 light chain 9606
224 4TQE 1 L If kappa light chain 10090
225 4TQE 2 H Fab heavy chain 10090
226 3ZKQ 2 D XA4813 9844
227 4I13 2 B Protein ca1697 (nanobody) 9844
228 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
229 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
230 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
231 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
232 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
233 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
234 5C2U 1 B Nanobody Nanobody 9838
235 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
236 5VSI 2 L CH1/Ckappa Fab light chain 9606
237 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
238 1XFP 1 A heavy chain antibody VHH domain 9838
239 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
240 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
241 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
242 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
243 5JXA 1 H VRC03 Heavy chain 9606
244 5JXA 2 L VRC03 Light chain 9606
245 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
246 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
247 4POY 1 A VHH-metal 9844
248 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
249 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
250 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
251 5NLW 1 A nanobody Nb36 9844
252 3CDC 1 A, B Light Chain Amyloidogenic 9606
253 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
254 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
255 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
256 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
257 3NTC 1 L Fab light chain 10090
258 3NTC 2 H Fab heavy chain 10090
259 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
260 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
261 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
262 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
263 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
264 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
265 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
266 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
267 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
268 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
269 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
270 6BE3 1 H Fab (F598) Heavy Chain 9606
271 6BE3 2 L Fab (F598) Light Chain 9606
272 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
273 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
274 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
275 3G9A 2 B Minimizer 9838
276 4NWU 1 H APE1551 Ab Fab heavy chain 9606
277 4NWU 2 L APE1551 Ab Fab light chain 9606
278 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
279 1KGC 1 D T-cell receptor alpha chain 9606
280 1KGC 2 E T-cell receptor beta chain 9606
281 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
282 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
283 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
284 6FRC 2 B Human T-Cell Receptor beta Chain 9606
285 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
286 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
287 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
288 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
289 5EWI 1 H VRC38.01 Heavy Chain 9606
290 5EWI 2 L VRC38.01 Light Chain 9606
291 5E2W 1 L AT8 LIGHT CHAIN 10090
292 5E2W 2 H AT8 HEAVY CHAIN 10090
293 5MYK 1 A Fab c#17 light chain 10090
294 5MYK 2 B Fab c#17 heavy chain 10090
295 6FUQ 1 A Human F11 T-Cell Receptor 9606
296 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
297 4NZR 1 H PGT135 heavy chain Fab 9606
298 4NZR 2 L PGT135 light chain Fab 9606
299 5MYO 1 A, C Fab c#6 light chain 10090
300 5MYO 2 B, D Fab c#6 heavy chain 10090
301 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
302 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
303 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
304 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
305 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
306 5UEL 1 H 354NC102 Fab Heavy Chain 9606
307 5UEL 2 L 354NC102 Fab Light Chain 9606
308 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
309 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
310 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
311 2P43 2 B ANTIBODY CAB-RN05 9838
312 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
313 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
314 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
315 5E2V 1 L AT8 LIGHT CHAIN 10090
316 5E2V 2 H AT8 HEAVY CHAIN 10090
317 4KRN 1 A Nanobody/VHH domain EgA1 9844
318 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
319 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
320 4GFT 2 B Nanobody 9844
321 4TVS 2 a, b VHH Domain BS-1 30538
322 4W6Y 2 B Nanobody NbFedF9 9844
323 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
324 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
325 6EZW 1 B VHH antibody BCD090-M2 9844
326 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
327 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
328 5JUE 1 L light chain of UIC2 Fab 10090
329 5JUE 2 H heavy chain of UIC2 Fab 10090
330 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
331 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
332 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
333 1UAC 2 H Ig VH,anti-lysozyme 10090
334 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
335 5JR1 1 H 10E8 heavy chain 9606
336 5JR1 2 L 10E8 mature light chain 9606
337 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
338 6CA7 1 L PCT64_13C light chain 9606
339 6CA7 2 H PCT64_13C heavy chain 9606
340 5VF6 1 A single chain variable fragment 9031
341 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
342 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
343 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
344 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
345 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
346 6FR9 2 B T-Cell Receptor F11 beta chain 9606
347 5OB5 2 H fAb Heavy chain 9606
348 5OB5 3 L fAb Light chain 9606
349 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
350 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
351 5I66 1 A 8B6 antibody, heavy chain 10090
352 5I66 2 B 8B6 antibody, light chain 10090
353 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
354 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
355 6BZY 1 H 22D11 Heavy Chain 10090
356 6BZY 2 L 22D11 Light Chain 10090
357 3QQ9 1 C, L 101F LIGHT CHAIN 10090
358 3QQ9 2 D, H 101F HEAVY CHAIN 10090
359 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
360 5TKK 3 L mouse antibody vFP5.01 light chain 10090
361 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
362 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
363 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
364 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
365 5W6C 1 H UCA Fab heavy chain 9606
366 5W6C 2 L UCA Fab light chain 9606
367 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
368 5I1K 1 L FAB LIGHT CHAIN 9606
369 5I1K 2 H FAB HEAVY CHAIN 9606
370 3OZ9 1 L Fab NC-1 kappa light chain 10090
371 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
372 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
373 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
374 5V7U 1 L CBTAU-22.1 Fab light chain 9606
375 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
376 5UEA 1 A, H Fab Heavy Chain 9606
377 5UEA 3 B, L Fab Light Chain 9606
378 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
379 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
380 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
381 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
382 3G5Y 1 A 175 light chain 10090
383 3G5Y 2 B 175 heavy chain 10090
384 5O02 2 C Nanobody (VHH) Nano-4 30538
385 5NMV 1 L Fab light chain 10088
386 5NMV 2 H Fab heavy chain 10088
387 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
388 4N8C 2 L, M Light chain of monoclonal antibody 10090
389 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
390 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
391 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
392 4HGW 1 A Antibody Fab fragment, light chain 10090
393 4HGW 2 B Antibody Fab fragment, heavy chain 10090
394 1NLB 1 L antibody 19D9D6 light chain 10090
395 1NLB 2 H antibody 19D9D6 heavy chain 10090
396 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
397 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
398 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
399 3VFG 1 L 3F8 Light Chain 10090
400 3VFG 2 H 3F8 Heavy Chain 10090
401 4X7F 2 C, D Nano-25 Nanobody 30538
402 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
403 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
404 3QRG 1 L Fab light chain 9606
405 3QRG 2 H Fab heavy chain Fd fragment 9606
406 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
407 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
408 5M6A 1 A, B, C, D Bence-Jones light chain 9606
409 4LLY 2 B, D light chain Clambda 9606
410 4LGR 2 B Camelid nanobody (VHH3) 30538
411 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
412 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
413 5EZI 1 H Fab c12 heavy chain 9606
414 5EZI 2 L Fab c12 Light chain 9606
415 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
416 4K23 1 H anti-uPAR antibody, heavy chain 10090
417 4K23 2 L anti-uPAR antibody, light chain 10090
418 5J57 2 B VHH single chain antibody V5E1 30538
419 3NCJ 1 L Fab15 Mut8 light chain 9606
420 3NCJ 2 H Fab15 Mut8 heavy chain 9606
421 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
422 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
423 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
424 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
425 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
426 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
427 5W05 1 L M59 FAB LIGHT CHAIN 10090
428 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
429 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
430 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
431 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
432 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
433 5OMM 2 C Nanobody (VHH) Nano-14 30538
434 5E03 1 A mouse CTLA-4 nanobody 10090
435 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
436 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
437 4M61 1 A, C Fab A52 light chain 10090
438 4M61 2 B, D Fab A52 heavy chain 10090
439 5LZ0 1 A, B PorM nanobody 9844
440 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
441 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
442 1UM5 1 L Antibody 21H3 L chain 10090
443 1UM5 2 H Antibody 21H3 H chain 10090
444 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
445 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
446 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
447 4NWT 1 L APE1531 Ab Fab light chain 9606
448 4NWT 2 H APE1531 Ab Fab heavy chain 9606
449 3WHX 1 A mAb Fab H fragment 10090
450 3WHX 2 B mAb Fab L fragment 10090
451 3NA9 1 L Fab15 light chain 9606
452 3NA9 2 H Fab15 heavy chain 9606
453 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
454 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
455 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
456 6FUO 2 B Human F11 T-Cell Receptor 9606
457 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
458 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
459 4LRI 1 A, B MSL-109 Light Chain 9606
460 4LRI 2 C, P MSL-109 Heavy Chain 9606
461 2XXC 1 B CAMELID VHH 9 30538
462 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
463 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
464 4JN2 1 A, L anti dabigatran Fab 10090
465 4JN2 2 B, H anti dabigatran Fab 10090
466 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
467 4XBE 2 H 4E10 Fab heavy chain 9606
468 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
469 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
470 6BE2 1 H Fab (F598) Heavy Chain 9606
471 6BE2 2 L Fab (F598) Light Chain 9606
472 3QYC 1 A, B VH domain of IgG molecule 9606
473 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
474 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
475 4JFZ 1 L Fab light chain 9606
476 4JFZ 2 H Fab heavy chain 9606
477 5VAK 2 B Nb914 Nanobody 9844
478 3WIF 1 A mAb Fab H fragment 10090
479 3WIF 2 B mAb Fab L fragment 10090
480 5U6A 1 A Light Chain 9606
481 5U6A 2 B Heavy Chain 9606
482 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
483 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
484 3MBX 1 L X836 LIGHT CHAIN 10090
485 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
486 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
487 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
488 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
489 2XXM 2 B CAMELID VHH 9 30538
490 6APC 1 H Epididymis luminal protein 214 9606
491 6APC 2 L IGL@ protein 9606
492 5IR3 1 A Ig lambda chain V-VI region AR 9606
493 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
494 4HHA 1 A Fab KE5 Fab fragment KE5 9606
495 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
496 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
497 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
498 4RGO 2 H 14G8 heavy chain Fab 10090
499 4RGO 3 L 14G8 light chain Fab 10090
500 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
501 5GRY 1 A, G diabody 9606
502 5UEK 2 H Fab 12E Heavy Chain 9606
503 5UEK 3 L Fab 12E Light Chain 9606
504 3NAA 1 L Fab15 Mut5 light chain 9606
505 3NAA 2 H Fab15 Mut5 heavy chain 9606
506 1Q0X 1 L Fab 9B1, light chain 10090
507 1Q0X 2 H Fab 9B1, heavy chain 10090
508 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
509 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
510 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
511 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
512 5JDS 1 B Nanobody 9835
513 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
514 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
515 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
516 5IK3 2 B, D 1E03 Fab fragment light chain 9606
517 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
518 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
519 5XLI 1 a, b FabL 10090
520 5XLI 2 c, d FabH 10090
521 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
522 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
523 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
524 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
525 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
526 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
527 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
528 4WUK 1 H CH65 heavy chain 9606
529 4WUK 2 L CH65 light chain 9606
530 5L8L 2 B New antigen receptor variable domain 168098
531 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
532 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
533 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
534 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
535 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
536 5JOP 1 D, L Fab 14.22 light chain 10090
537 5JOP 2 E, H Fab14.22 heavy chain 10090
538 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
539 4HPO 1 H CH58 Fab heavy chain 9606
540 4HPO 2 L CH58 Fab light chain 9606
541 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
542 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
543 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
544 5UKN 2 L DH522UCA Fab fragment light chain 9544
545 4AIZ 1 A, C, D V2-17 PROTEIN 9606
546 4AIZ 2 B V2-17 PROTEIN 9606
547 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
548 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
549 5L21 2 B VHH-C2 30538
550 5IT2 1 H heavy chain 9606
551 5IT2 2 L light chain 9606
552 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
553 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
554 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
555 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
556 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
557 2W59 1 A, B IGY FCU3-4 9031
558 5FWO 1 A NANOBODY 9844
559 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
560 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
561 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
562 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
563 4L1H 1 A Ig kappa chain V-I region Rei 9606
564 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
565 5MO3 3 L Fab of monoclonal antibody, light chain 10090
566 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
567 5GZ0 1 A, C FM329 light chain 1383439
568 5GZ0 2 B, D FM329 heavy chain 1383439
569 3B9V 1 A, B, C, D heavy chain variable domain 9606
570 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
571 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
572 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
573 6BQB 1 L MGG4 Fab light chain 9606
574 6BQB 2 H MGG4 Fab heavy chain 9606
575 4PUB 1 H DX-2930 HEAVY CHAIN 9606
576 4PUB 2 L DX-2930 LIGHT CHAIN 9606
577 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
578 6B14 2 L Light chain of Fab BL3-6S97N 10090
579 5N88 1 A, H VH59 antibody 9606
580 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
581 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
582 5TEZ 4 I TCR F50 alpha chain 9606
583 5TEZ 5 J TCR F50 beta chain 9606
584 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
585 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
586 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
587 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
588 5GS3 1 A, H diabody protein 9606
589 3BD3 1 A, B catalytic antibody 10090
590 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
591 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
592 2OTU 1 A, C, E, G Fv light chain variable domain 10090
593 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
594 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
595 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
596 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
597 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
598 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
599 5VKD 2 H Fab Heavy Chain 9606
600 5VKD 3 L Fab light chain 9606
601 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
602 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
603 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
604 5XHG 1 A, C polypeptide(L) 562
605 5XHG 2 B, D polypeptide(H) 562
606 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
607 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
608 5L8J 2 B New antigen receptor variable domain 168098
609 3UYR 1 H antibody Fab heavy chain 10090
610 3UYR 2 L antibody Fab light chain 10090
611 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
612 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
613 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
614 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
615 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
616 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
617 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
618 3OAZ 2 K, L Fab 2G12, light chain 9606
619 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
620 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
621 1T6V 2 N, O novel antigen receptor 7801
622 1ZAN 1 L Fab AD11 Light Chain 10116
623 1ZAN 2 H Fab AD11 Heavy Chain 10116
624 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
625 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
626 4N0Y 1 H IGH526 Heavy Chain 9606
627 4N0Y 2 L IGH526 Light Chain 9606
628 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
629 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
630 5MTH 1 A, H antibody Fab heavy chain 10090
631 5MTH 2 B, L antibody Fab light chain 10090
632 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
633 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
634 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
635 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
636 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
637 1RZF 1 L Fab E51 light chain 9606
638 1RZF 2 H Fab E51 heavy chain 9606
639 4N1C 1 A, B immunoglobulin variable light chain domain 9606
640 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
641 4KTE 2 L GE148 Light Chain Fab 9544
642 5I8O 1 H HMM5 antibody heavy chain 9606
643 5I8O 2 L HMM5 antibody light chain 9606
644 4OUO 1 A anti Bla g 1 scFv 9031
645 4JG0 1 L Fab light chain 9606
646 4JG0 2 H Fab heavy chain 9606
647 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
648 4YGV 2 B, L aDabi-Fab2a light chain 9606
649 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
650 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
651 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
652 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
653 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
654 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
655 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
656 3EO0 1 A, C GC-1008 Fab Light Chain 10090
657 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
658 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
659 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
660 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
661 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
662 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
663 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
664 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
665 6FUR 2 B, D Human F11 T-Cell Receptor 9606
666 4POU 2 B VHH Antibody 9844
667 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
668 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
669 4FQI 3 H antibody CR9114 heavy chain Fab 9606
670 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
671 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
672 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
673 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
674 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
675 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
676 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
677 4JHA 2 L D25 light chain 9606
678 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
679 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
680 4PTT 1 A Antibody pn132p2C05, light chain 9606
681 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
682 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
683 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
684 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
685 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
686 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
687 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
688 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
689 2P42 2 B, D ANTIBODY CAB-RN05 9838
690 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
691 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
692 6CPH 1 D TCR alpha chain 9606
693 6CPH 2 E TCR beta chain 9606
694 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
695 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
696 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
697 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
698 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
699 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
700 4DGV 1 H HCV1 Heavy Chain Fab 9606
701 4DGV 2 L HCV1 Light Chain 9606
702 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
703 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
704 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
705 5TH2 1 A, C cetuximab Fab, light chain 10090
706 5TH2 2 B, D cetuximab Fab, heavy chain 10090
707 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
708 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
709 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
710 5I8K 1 L HHH1 Fab Light chain 9606
711 5I8K 2 H HHH1 Fab Heavy chain 9606
712 4QLR 1 A, B Llama nanobody n02 VH domain 9844
713 5J56 2 B VHH single chain antibody V1C7 30538
714 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
715 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
716 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
717 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
718 1YNL 1 L Ig gamma light chain 10090
719 1YNL 2 H Ig gamma heavy chain 10090
720 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
721 5EPM 2 B, F Antibody Fab fragment light chain 10090
722 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
723 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
724 5VH5 1 A Infliximab Fc 10090
725 3UMT 1 A scFv heavy chain and light chain 10090
726 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
727 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
728 4NUJ 1 A PGT152 light chain 9606
729 4NUJ 2 B PGT152 heavy chain 9606
730 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
731 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
732 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
733 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
734 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
735 3U2S 2 B, L PG9 light chain 9606
736 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
737 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
738 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
739 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
740 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
741 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
742 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
743 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
744 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
745 4NUG 1 L PGT151 light chain 9606
746 4NUG 2 H PGT151 heavy chain 9606
747 3IU4 1 H chP3 Fab heavy chain 10090
748 3IU4 2 L chP3 Fab light chain 10090
749 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
750 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
751 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
752 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
753 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
754 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
755 1P7K 1 A, L antibody light chain FAB 10090
756 1P7K 2 B, H antibody heavy chain FAB 10090
757 4NBX 2 B A20.1 VHH 9844
758 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
759 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
760 3RVV 2 C 4C1 - light chain 10090
761 3RVV 3 D 4C1 - heavy chain 10090
762 4HEP 2 G vHH17 domain 9844
763 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
764 3P0Y 2 H Fab DL11 heavy chain 9606
765 3P0Y 3 L Fab DL11 light chain 9606
766 4NPY 1 A, L germline PGT121 light chain Fab 9606
767 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
768 6ANA 2 H LL2 Fab Heavy Chain 10090
769 6ANA 3 L LL2 Fab Light Chain 10090
770 5IBU 1 B, L 6652 Light Chain 9606
771 5IBU 2 G, H 6652 Heavy Chain 9606
772 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
773 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
774 5VPL 2 C 4C1 - LIGHT CHAIN 10090
775 5VPL 3 D 4C1 - HEAVY CHAIN 10090
776 6AOD 1 A FXIa Antibody FAB Light Chain 9606
777 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
778 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
779 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
780 2YPV 2 H FAB 12C1 10090
781 2YPV 3 L FAB 12C1 10090
782 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
783 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
784 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
785 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
786 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
787 4JY5 1 L PGT122 light chain Fab 9606
788 4JY5 2 H PGT122 heavy chain Fab 9606
789 6ELE 1 A, H fAB heavy chain 9606
790 6ELE 2 B, L fAB light chain 9606
791 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
792 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
793 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
794 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
795 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
796 6B5R 1 H CIS42 Fab Heavy chain 9606
797 6B5R 2 L CIS42 Fab Light chain 9606
798 5IML 2 B Nanobody 9835
799 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
800 3NAC 1 L Fab15 Mut7 light chain 9606
801 3NAC 2 H Fab15 Mut7 heavy chain 9606
802 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
803 3A6C 2 H IG VH, anti-lysozyme 10090
804 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
805 2DQD 2 H Ig VH,anti-lysozyme 10090
806 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
807 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
808 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
809 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
810 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
811 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
812 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
813 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
814 1Q72 1 L Fab M82G2, Light chain 10090
815 1Q72 2 H Fab M82G2, Heavy chain 10090
816 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
817 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
818 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
819 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
820 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
821 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
822 4YHO 1 H aDabi-Fab3 heavy chain 9606
823 4YHO 2 L aDabi-Fab3 light chain 9606
824 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
825 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
826 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
827 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
828 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
829 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
830 4DGY 1 H HCV1 Heavy Chain Fab 9606
831 4DGY 2 L HCV1 Light Chain 9606
832 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
833 3A67 2 H IG VH, anti-lysozyme 10090
834 2APB 1 A T-cell receptor beta chain V 10116
835 2APX 1 A T cell receptor beta chain V 10116
836 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
837 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
838 6EH6 2 B Human T Cell Receptor BetaChain 9606
839 5EN2 1 A GD01 heavy chain 10090
840 5EN2 2 B GD01 light chain 10090
841 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
842 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
843 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
844 1J1X 2 H Ig VH,anti-lysozyme 10090
845 5L8K 2 B New antigen receptor variable domain 168098
846 5M2J 2 D Anti-(ED-B) scFV 9606
847 3MXW 2 L 5E1 light chain 9606
848 3MXW 3 H 5E1 heavy chain 9606
849 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
850 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
851 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
852 2DQC 2 H Ig VH,anti-lysozyme 10090
853 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
854 1J1O 2 H Ig VH,anti-lysozyme 10090
855 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
856 3EO9 1 L Efalizumab Fab fragment, light chain 9606
857 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
858 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
859 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
860 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
861 4M62 2 H, I GEP2 FV heavy chain 9606
862 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
863 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
864 5IVO 1 A BC2-nanobody 30538
865 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
866 1J1P 2 H Ig VH,anti-lysozyme 10090
867 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
868 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
869 4NBZ 2 B, D A26.8 VHH 9844
870 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
871 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
872 5WUV 1 L light chain 9606
873 5WUV 2 H heavy chain 9606
874 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
875 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
876 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
877 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
878 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
879 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
880 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
881 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
882 5AYU 2 H Ig VH,anti-lysozyme 10090
883 4JM4 1 H PGT 135 Heavy Chain Fab 9606
884 4JM4 2 L PGT 135 Light Chain Fab 9606
885 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
886 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
887 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
888 3A6B 2 H IG VH, anti-lysozyme 10090
889 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
890 2DQJ 2 H Ig VH,anti-lysozyme 10090
891 5F21 2 B nanobody MU375 9844
892 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
893 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
894 6B0G 1 C 1245 Antibody, Light Chain 9606
895 6B0G 2 D 1245 Antibody, Heavy Chain 9606
896 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
897 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
898 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
899 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
900 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
901 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
902 6D0X 1 A 2140 Antibody, heavy chain 9606
903 6D0X 2 B 1210 Antibody, light chain 9606
904 2Q86 1 A, C Valpha14 TCR extracellular domain 10090
905 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
906 2P44 2 B ANTIBODY CAB-RN05 9838
907 6BE4 1 H Fab (F598) Heavy Chain 9606
908 6BE4 2 L Fab(F598) Light Chain 9606
909 6FRB 1 A Human T-Cell Receptor F11 alpha chain 9606
910 6FRB 2 B Human T-Cell Receptor F11 beta Chain 9606
911 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
912 5TPP 1 L DH270.5 Fab heavy chain 9606
913 5TPP 2 H DH270.5 Fab light chain 9606
914 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
915 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
916 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
917 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
918 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
919 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
920 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
921 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
922 5TP3 1 A, B F-VHH-4 9844
923 5D7K 1 D MAV36 TCR Alpha Chain 9606
924 5D7K 2 E MAV36 TCR Beta Chain 9606
925 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
926 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
927 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
928